Researchers report progress in looking for signs of lung cancer in the blood.

Delfi Diagnostics is launching its first liquid biopsy test, fulfilling the company’s own, years-long prophecy to offer a new blood-based tool for the screening of lung cancer. Its Firstlook Lung test ...

PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced ...

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that two abstracts will be presented at ...

Removing a patient’s race from an equation used to assess lung function — a change called for by health equity advocates — would mean that the lung disease of nearly half a million Black Americans ...

Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be getting screened for ...

CLEVELAND — November is Lung Cancer Awareness month. The disease is the leading cause of cancer death around the world, and according to the American Lung Association, nearly a quarter of a million ...

Hummingbird Diagnostics believes its screening test can help uncover early cases of lung cancer by plucking small, flitting pieces of tumor RNA from the bloodstream—and potentially provide an ...

Background Interstitial lung disease (ILD) is a major pulmonary complication of idiopathic inflammatory myopathy (IIM), where ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the ...